Company profile: Ceterix
1.1 - Company Overview
Company description
- Provider of novel surgical tools for arthroscopic procedures, enabling surgeons to place stitches in tight joint compartments while protecting surrounding structures such as nerves, arteries and cartilage. Products include the NovoStitch Plus Meniscal Repair System for repairing complex meniscal tears, including horizontal, radial, and root tears often left untreated or treated by meniscectomy.
Products and services
- Arthroscopic Stitch Placement Technology: Enables surgeons to place stitches in very tight joint compartments while protecting nerves, arteries, and cartilage, custom-engineered system applied across numerous knee arthroscopic procedures
- Novel Arthroscopic Surgical Tools Portfolio: Develops novel instruments for arthroscopy that architect stitch placement within confined joint spaces and shield sensitive structures, arthroscopy-optimized components utilized in knee procedures
- NovoStitch Plus Meniscal Repair System: Allows surgeons to repair complex meniscal tears—including horizontal, radial, and root—that are often left untreated or treated by meniscectomy, meniscus-specific device engineers precise stitch placement in tight joint compartments
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Ceterix
Centerline Biomedical
HQ: United States
Website
- Description: Provider of the IOPS (Intra-Operative Positioning System), a 3D surgical navigation and visualization technology that improves endovascular procedure outcomes and reduces radiation exposure; used in FDA-cleared Endovascular Aortic Repair, Peripheral Artery Disease procedures, and structural heart interventions. Cleveland Clinic spin-off.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Centerline Biomedical company profile →
EndoVia Medical
HQ: United States
Website
- Description: Provider of physician-guided robotic systems for minimally invasive surgery, including the Laprotek robotic instrument system for procedures in general surgery, urology, gynecology, and bariatric surgery, and the ViaCath user interface and instrument control platform.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full EndoVia Medical company profile →
Tenaxis Medical
HQ: United States
Website
- Description: Provider of high-performance sealants and anti-adhesion agents for use in vascular and general surgery; develops and commercializes these products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tenaxis Medical company profile →
SonaCare Medical
HQ: United States
Website
- Description: Provider of minimally invasive HIFU technologies for prostate tissue ablation, including Sonablate HIFU with real-time ultrasound feedback and safety features like Tissue Change Monitoring, and Sonablate Fusion, an integrated MRI/Ultrasound fusion system for more accurate prostate tissue targeting during HIFU procedures.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SonaCare Medical company profile →
Checkpoint Surgical
HQ: United States
Website
- Description: Provider of surgical devices and education enabling nerve and muscle localization, evaluation, protection, and repair. Offerings include biphasic CHECKPOINT Stimulators for safe intraoperative nerve/muscle stimulation; CHECKPOINT Guardian and Gemini stimulators for controlled, continuous activation; NeuroShield chitosan biomaterial for nerve repair; Edge nerve cutting kit; plus in-person and virtual peripheral nerve education programs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Checkpoint Surgical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Ceterix
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Ceterix
2.2 - Growth funds investing in similar companies to Ceterix
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Ceterix
4.2 - Public trading comparable groups for Ceterix
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →